CALL - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Market Closed - Boerse Frankfurt Warrants 11:21:26 31/05/2024 pm IST | ||
| 0.28 EUR | -39.13% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.28 | -39.13% |
| 30/24/30 | 0.46 | +27.78% |
| 29/24/29 | 0.36 | +16.13% |
| 28/24/28 | 0.31 | -27.91% |
| 27/24/27 | 0.43 | -2.27% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 11:21 pm IST
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD5H4H |
| ISIN | DE000VD5H4H9 |
| Date issued | 03/05/2024 |
| Strike | 83.56 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.73 € |
|---|---|
| Lowest since issue | 0.16 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Certificates
- Certificat
